Acne vulgaris, I: Pathogenesis and diagnosis

Cutis

Volumn 70, Issue 2, 2002, Pages 101-105

  Oberemok, Steve S ^a   Shalita, Alan R ^a  

^a SUNY Downstate Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACNE VULGARIS; ADOLESCENT; ADULT; DIFFERENTIAL DIAGNOSIS; HOSPITALIZATION; HUMAN; PATIENT SATISFACTION; REVIEW;

ACNE VULGARIS; ADOLESCENT; ADULT; DIAGNOSIS, DIFFERENTIAL; HUMANS; PATIENT SATISFACTION; SEVERITY OF ILLNESS INDEX;

EID: 0036691494     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Koo J. The psychological impact of acne: patient's perceptions. J Am Acad Dermatol. 1995;32:S26-S30.
2. Plewig G, Fulton JE, Kligman AM. Cellular dynamics of comedo formation in acne vulgaris. Arch Dermatol Forsch. 1971;242:12-29.
3. Vowels BR, Yang S, Leyden JJ. Induction of proinflammatory cytokines by a soluble factor of P acnes: implications for chronic inflammatory acne. Infect Immun. 1995;63:3158-3165.
4. Knaggs HE, Holland DB, Morris C, et al. Quantification of cellular proliferation in acne using the monoclonal antibody Ki-67. J Soc Invest Dermatol. 1994;102:89-92.
5. Cunliffe WJ, Holland DB, Clark SM, et al. Comedogenesis: some new aetiological, clinical and therapeutic strategies. Br J Dermatol. 2000;142:1084-1091.
6. Kligman AM, Katz AC. Pathogenesis of acne vulgaris. Arch Dermatol. 1968;98:53-57.
7. Motoyoshi K. Enhanced comedo formation in rabbit ear skin by squalene and oleic acid peroxides. Br J Dermatol. 1983;109:191-198.
8. Kealey T. Hypovitaminosis A of follicular duct as a cause of acne vulgaris [letter]. Lancet. 1988;2:449.
9. Guy R, Greem MR, Kealey T. Modeling acne in vitro. J Invest Dermatol. 1996;106:176-182.
10. Thiboutot D, Gilliland K, Light J, et al. Androgen metabolism in sebaceous glands from subjects with and without acne. Arch Dermatol. 1999;135:1041-1045.
11. Pochi PE, Strauss JS, Rao RS, et al. Plasma testosterone excretion and sebum production in males with acne vulgaris. J Clin Endocrinol Metab. 1965;51:287-291.
12. Shalita AR, Lee WL. Inflammatory acne. Dermatol Clin. 1983;1:361-364.
13. Weeks JG, McCarty L, Black T, et al. The inability of a bacterial lipase inhibitor to control acne vulgaris. J Invest Dermatol. 1977;69:236-243.
14. Lee WL, Shalita AR, Suntharalingam K, et al. Neutrophil chemotaxis by Propionibacterium acnes lipase and its inhibition. Infect Immun. 1982;35:71-78.
15. Webster GF, Leyden JJ. Characterization of serum-independent polymorphonuclear leukocyte chemotactic factors produced by Propionibacterium acnes. Inflammation. 1980;4:261-269.
16. Norris JFB, Cunliffe WJ. A histological and immunocytochemical study of early acne lesions. Br J Dermatol. 1988;118:651-659.
17. Puhvel SM, Barfatani M, Warnick M. Study of antibody levels to Corynebacterium acnes. Arch Dermatol. 1964;90:421-427.
18. Allaker RP, Greenman S. The production of inflammatory compounds by Propionibacterium acnes and other skin organisms. Br J Dermatol. 1987;117:175-183.
19. Ingham E, Eady EA, Goodwin CE, et al. Proinflammatory levels of IL-1-like bioactivity are present in the majority of open comedones in acne vulgaris. J Invest Dermatol. 1992;98:895-901.
20. Puhvel SM, Hoffman LK. The production of hyaluronidase by Corynebacterium acnes. J Invest Dermatol. 1972;58:66-70.
21. Report of the Consensus Conference on Acne Classification. J Am Acad Dermatol. 1991;24:495-500.